SAN DIEGO July 10 2017 PRNewswire Arena Pharmaceuticals Inc. NASDAQ ARNA today announced positive Phase 2 results for ralinepag an investigational longacting orally administered prostacyclin receptor agonist under development for the treatment of pulm...
↧